$303.85
▲ +0.3% Today
as of Jul 22, 12:02 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 3
● 18
▼ 1
BofA Securities Adjusts Cencora Price Target to $310 From $285
Cencora Earnings Preview: What to Expect
Health Insurance Providers Stocks Q1 In Review: Cencora (NYSE:COR) Vs Peers
Overview
52-week range
$245
$378
44% of range
Avg surprise (last 3)
+4.4%
Avg reaction (last 2)
-6.3%
50% positive
Latest IV / EM
36%
EM ±8.3% · $300 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $4.75 | $4.80 | -1.0% | +7.5% | -17.4% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $2.87 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $4.00 | $3.78 | +5.8% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $4.42 | $4.08 | +8.3% | — | +4.7% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $2.50 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $2.42 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $2.09 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $2.98 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $2.35 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | BMO | $4.37 | $4.00 | +9.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $78.36B | $85.93B | — | $80.66B | $75.45B | $81.49B | — | $74.24B |
| Cost of revenue | $74.77B | $82.86B | — | $77.76B | $72.39B | $78.93B | — | $71.83B |
| Gross profit | $3.59B | $3.07B | — | $2.91B | $3.06B | $2.56B | — | $2.41B |
| Operating income | $1.14B | $760M | — | $868M | $1.04B | $706M | — | $672M |
| Net income | $1.64B | $560M | — | $687M | $718M | $489M | — | $483M |
| EPS (diluted) | $8.40 | $2.87 | — | $3.52 | $3.68 | $2.50 | — | $2.42 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.18B | $1.75B | $4.36B | $2.23B | $1.98B | $3.22B | $3.13B | $3.31B |
| Inventory | $20.01B | $24.08B | $20.49B | $20.14B | $18.97B | $20.51B | $19.00B | $18.30B |
| Total current assets | $53.14B | $54.15B | $52.24B | $48.81B | $46.53B | $49.99B | $47.72B | $47.31B |
| Total assets | $81.65B | $78.36B | $76.59B | $73.96B | $71.19B | $69.05B | $67.10B | $66.77B |
| Long-term debt | $12.18B | $7.58B | $7.54B | $8.04B | $7.09B | $5.94B | $3.81B | $4.17B |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $3.40B | $1.91B | $1.51B | $1.98B | $1.01B | $227M | $646M | $925M |